Science Explorer Back to mapMap
Discussion
Company · Winchester · United Kingdom

Biopharma Technology (United Kingdom)

biopharma.co.ukROR OpenAlex
Research works
63
▲ 65% vs 2018-21
Citations
465
7.4 per fractional work
Top-10% rate
10.3%
all institutions 10.0%
Open access
53%
world 40%
International
41%
world 18%
Biopharma Technology (United Kingdom)

Not ranked overall: Biopharma Technology (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Biopharma Technology (United Kingdom) work in?

In 2022-now, 43% of research at Biopharma Technology (United Kingdom) is in Health Sciences, 41% in Life Sciences. Its largest fields are Medicine (42%), Biochemistry, Genetics and Molecular Biology (26%), Immunology and Microbiology (7%). It does 2.1× the world's share of Life Sciences.

Health Sciences: 11 fractional works · 42.7% of its workMedicine: 11 fractional works · 42.0% of its workOncology: 2 fractional works · 6.2% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 5.2% of its workSurgery: 1 fractional works · 4.1% of its workPharmacology: 1 fractional works · 3.9% of its workPulmonary and Respiratory Medicine: 1 fractional works · 3.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.9% of its workPhysiology: 0 fractional works · 1.9% of its workInfectious Diseases: 0 fractional works · 1.8% of its workOphthalmology: 0 fractional works · 1.7% of its workGenetics: 0 fractional works · 1.6% of its workDermatology: 0 fractional works · 1.4% of its workEmergency Medicine: 0 fractional works · 1.3% of its workInternal Medicine: 0 fractional works · 1.3% of its workReproductive Medicine: 0 fractional works · 1.3% of its workEpidemiology: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 0.8% of its workHematology: 0 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.5% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.2% of its workObstetrics and Gynecology: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.7% of its workMedical Laboratory Technology: 0 fractional works · 0.7% of its workDentistry: 0 fractional works · 0.0% of its workLife Sciences: 11 fractional works · 41.4% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 25.6% of its workMolecular Biology: 5 fractional works · 18.1% of its workCancer Research: 1 fractional works · 3.6% of its workBiotechnology: 0 fractional works · 1.2% of its workGenetics: 0 fractional works · 0.8% of its workClinical Biochemistry: 0 fractional works · 0.7% of its workEndocrinology: 0 fractional works · 0.7% of its workMolecular Medicine: 0 fractional works · 0.5% of its workImmunology and Microbiology: 2 fractional works · 6.5% of its workImmunology: 2 fractional works · 6.5% of its workNeuroscience: 1 fractional works · 4.2% of its workCellular and Molecular Neuroscience: 1 fractional works · 2.5% of its workNeurology: 0 fractional works · 1.0% of its workCognitive Neuroscience: 0 fractional works · 0.4% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.3% of its workPharmaceutical Science: 0 fractional works · 1.7% of its workPharmacology: 0 fractional works · 1.2% of its workToxicology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 1.8% of its workPlant Science: 0 fractional works · 0.9% of its workAquatic Science: 0 fractional works · 0.4% of its workFood Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 3 fractional works · 11.6% of its workEngineering: 1 fractional works · 3.5% of its workBiomedical Engineering: 1 fractional works · 2.0% of its workElectrical and Electronic Engineering: 0 fractional works · 0.7% of its workAerospace Engineering: 0 fractional works · 0.4% of its workMechanics of Materials: 0 fractional works · 0.4% of its workComputer Science: 1 fractional works · 2.3% of its workArtificial Intelligence: 0 fractional works · 1.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemistry: 0 fractional works · 1.7% of its workOrganic Chemistry: 0 fractional works · 1.0% of its workSpectroscopy: 0 fractional works · 0.7% of its workEarth and Planetary Sciences: 0 fractional works · 1.3% of its workPaleontology: 0 fractional works · 0.9% of its workGeochemistry and Petrology: 0 fractional works · 0.4% of its workEnvironmental Science: 0 fractional works · 1.0% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.7% of its workEnvironmental Engineering: 0 fractional works · 0.3% of its workEnergy: 0 fractional works · 0.9% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.9% of its workChemical Engineering: 0 fractional works · 0.7% of its workCatalysis: 0 fractional works · 0.7% of its workMathematics: 0 fractional works · 0.3% of its workStatistics and Probability: 0 fractional works · 0.3% of its workSocial Sciences: 1 fractional works · 4.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 2.6% of its workEconomics and Econometrics: 1 fractional works · 2.6% of its workPsychology: 0 fractional works · 1.3% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.7% of its workSocial Psychology: 0 fractional works · 0.7% of its workDecision Sciences: 0 fractional works · 0.4% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.4% of its workALL ITS WORKBiopharmaTechnology…26fractional works, 2022-now
Life Sciences41%Physical Sciences12%Health Sciences43%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine1142.0%
    2. Health Professions00.7%
    3. Dentistry00.0%
    1. Biochemistry, Genetics and Molecular Biology725.6%
    2. Immunology and Microbiology26.5%
    3. Neuroscience14.2%
    4. Pharmacology, Toxicology and Pharmaceutics13.3%
    5. Agricultural and Biological Sciences01.8%
    1. Engineering13.5%
    2. Computer Science12.3%
    3. Chemistry01.7%
    4. Earth and Planetary Sciences01.3%
    5. Environmental Science01.0%
    6. Energy00.9%
    7. Chemical Engineering00.7%
    8. Mathematics00.3%
    1. Economics, Econometrics and Finance12.6%
    2. Psychology01.3%
    3. Decision Sciences00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.39× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.81× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 6.45× its world share, 2 worksImmunology and Micro…Neuroscience: 2.59× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.32× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 1.86× its world share, 0 worksChemical EngineeringChemistry: 1.06× its world share, 0 worksChemistryComputer Science: 0.29× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.83× its world share, 0 worksEarth and Planetary …Energy: 0.99× its world share, 0 worksEnergyEngineering: 0.24× its world share, 1 worksEngineeringEnvironmental Science: 0.20× its world share, 0 worksEnvironmental ScienceMathematics: 0.22× its world share, 0 worksMathematicsDentistry: 0.10× its world share, 0 worksDentistryHealth Professions: 0.25× its world share, 0 worksHealth ProfessionsMedicine: 2.18× its world share, 11 worksMedicineDecision Sciences: 0.45× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.21× its world share, 1 worksEconomics, Econometr…Psychology: 0.43× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.3×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics9.32×1 works
  2. Immunology and Microbiology6.45×2 works
  3. Biochemistry, Genetics and Molecular Biology4.81×7 works
  4. Neuroscience2.59×1 works
  5. Medicine2.18×11 works
  6. Chemical Engineering1.86×0 works
  7. Economics, Econometrics and Finance1.21×1 works
  8. Chemistry1.06×0 works
  9. Energy0.99×0 works
  10. Earth and Planetary Sciences0.83×0 works
  11. Decision Sciences0.45×0 works
  12. Psychology0.43×0 works
  13. Agricultural and Biological Sciences0.39×0 works
  14. Computer Science0.29×1 works
  15. Health Professions0.25×0 works
  16. Engineering0.24×1 works
  17. Mathematics0.22×0 works
  18. Environmental Science0.20×0 works
  19. Dentistry0.10×0 works

Who are the top researchers at Biopharma Technology (United Kingdom)?

Ranked on the quality score, J.D. Marshall, D. Hill and C.A. Hill lead among researchers whose main affiliation is Biopharma Technology (United Kingdom).

  1. 1 J.D. Marshall United Kingdom · #2,874,698 worldwide 418 citations · 36 works
  2. 2 D. Hill United Kingdom · #3,663,127 worldwide 453 citations · 33 works
  3. 3 C.A. Hill United Kingdom · #4,697,441 worldwide 7 citations · 19 works
All ranked researchers at Biopharma Technology (United Kingdom)

What are the most cited papers from Biopharma Technology (United Kingdom)?

The most cited paper from Biopharma Technology (United Kingdom) is "Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis" (Mark Fisher, Steven D. Nathan, Christian Hill et al., 2017), with 105 citations. Next come "Prophylactic Ureteric Stents in Renal Transplant Recipients: A Multicenter Randomized Controlled Trial of Early Versus Late Removal" (79) and "Apatite nanoparticles strongly improve red blood cell cryopreservation by mediating trehalose delivery via enhanced membrane permeation" (75).

Most cited papers
#PaperReleasedCitations
1 Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis Mark Fisher, Steven D. Nathan, Christian Hill et al. · Journal of Managed Care & Specialty Pharmacy Open access Mar 2017 105
2 Prophylactic Ureteric Stents in Renal Transplant Recipients: A Multicenter Randomized Controlled Trial of Early Versus Late Removal Prakash A. Patel, Irene Rebollo‐Mesa, Elizabeth Ryan et al. · American Journal of Transplantation Open access 11 Feb 2017 79
3 Apatite nanoparticles strongly improve red blood cell cryopreservation by mediating trehalose delivery via enhanced membrane permeation Martin Štefanič, Kevin Ward, Harvey Tawfik et al. · Biomaterials Open access 18 Jun 2017 75
4 The Principles of Freeze-Drying and Application of Analytical Technologies Kevin R. Ward, Paul Matejtschuk · Methods in molecular biology Book chapter 14 Aug 2020 59
5 The Principles of Freeze-Drying Gerald D. J. Adams, Isobel Cook, Kevin R. Ward · Methods in molecular biology Book chapter 14 Nov 2014 55
All 77 most cited papers, with filters and sorting

Which keywords describe research at Biopharma Technology (United Kingdom)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer, Lymphoma, Glycosylation, Genome Engineering, RNA-Guided, Monoclonal Antibodies, Inflammation and Therapeutic Antibodies.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 11 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 11 words, with their numbers
  1. Cancer2▲ 5.8×13 topics
  2. Inflammation2▲ 3.0×13 topics
  3. Lymphoma1▲ 29×3 topics
  4. Oxidative Stress1▲ 2.9×10 topics
  5. Epidemiology1◆ 1.05×11 topics
  6. Genome Engineering1▲ 67×1 topic
  7. Glycosylation1▲ 38×3 topics
  8. Immunotherapy1▲ 5.7×4 topics
  9. Monoclonal Antibodies1▲ 46×3 topics
  10. RNA-Guided1▲ 67×1 topic
  11. Therapeutic Antibodies1▲ 57×2 topics

Which research topics does Biopharma Technology (United Kingdom) publish most on?

By volume in 2022-now: CRISPR and Genetic Engineering, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Cancer-related molecular mechanisms research.

CRISPR and Genetic Engineering: 1 fractional worksCAR-T cell therapy research: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer-related molecular…1Cancer-related molecular mechanisms research: 1 fractional worksGenetic Neurodegenerative Diseases: 1 fractional worksBiosensors and Analytical Detection: 0 fractional worksImmune Cell Function and…0Immune Cell Function and Interaction: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksRetinal Diseases and Treatments: 0 fractional worksCOVID-19 diagnosis using AI: 0 fractional works
Molecular BiologyOncologyRadiology, Nuclear Medicine and ImagingCancer Research4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 1 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Cancer-related molecular mechanisms research Cancer Research 1 works
  5. 5 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 1 works
  6. 6 Biosensors and Analytical Detection Biomedical Engineering 0 works
  7. 7 Immune Cell Function and Interaction Immunology 0 works
  8. 8 RNA Interference and Gene Delivery Molecular Biology 0 works
  9. 9 Retinal Diseases and Treatments Ophthalmology 0 works
  10. 10 COVID-19 diagnosis using AI Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.8%not open47.2%

World: 40% of research is openly available.

with international co-authors41.0%domestic only59.0%

World: 18% is written across borders.

How has Biopharma Technology (United Kingdom)'s research output changed?

Output in 2022-2025 was 65% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Biopharma Technology (United Kingdom) as a percentage of every work published that year, 0.000077% in 2024.

still counting0.00010%0.00020%Biopharma Technology (United Kingdom)0.00015% in 2025200020102020

Fractional works of Biopharma Technology (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Winchester

All research institutions in Winchester

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Biopharma Technology (United Kingdom). Posts are plain text and can be reported.